Aggressive systemic mastocytosis complicated by protein-losing enteropathy

Digestive and Liver Disease

Volumn 39, Issue 7, 2007, Pages 693-697

  Mickys, U ^a   Barakauskiene, A ^a   De Wolf Peeters, C ^b   Geboes, K ^b   De Hertogh, G ^b  

^a National Centre of Pathology   (Lithuania)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Mastocytosis; Protein losing enteropathies

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CD68 ANTIGEN; EOSIN; HEMATOXYLIN; METRONIDAZOLE; PREDNISONE; STEM CELL FACTOR RECEPTOR; TOLONIUM CHLORIDE; TRYPTASE;

ADULT; ARTICLE; ASCITES; BONE MARROW CELL; CASE REPORT; CELL AGGREGATION; CHRONIC DIARRHEA; CLINICAL EXAMINATION; CLOSTRIDIUM DIFFICILE; COLON POLYP; COLONOSCOPY; CYTOPLASM; DEHYDRATION; DISEASE SEVERITY; DUODENUM DISEASE; DUODENUM MUCOSA; FEMALE; GASTROINTESTINAL ENDOSCOPY; GIEMSA STAIN; HEMATOLOGIC MALIGNANCY; HISTIOCYTE; HOSPITAL ADMISSION; HUMAN; HYPOALBUMINEMIA; HYPOPROTEINEMIA; IMMUNOPHENOTYPING; INTESTINE BIOPSY; LABORATORY TEST; LAMINA PROPRIA; LEG EDEMA; LETHARGY; MALNUTRITION; MUSCLE WEAKNESS; NORMOCHROMIC NORMOCYTIC ANEMIA; PERIODIC ACID SCHIFF STAIN; PROTEIN LOSING GASTROENTEROPATHY; RESPIRATORY TRACT INFECTION; SPINDLE CELL; SYSTEMIC MASTOCYTOSIS; VOMITING;

ANTI-INFLAMMATORY AGENTS; BIOLOGICAL RESPONSE MODIFIERS; COLONOSCOPY; FEMALE; HUMANS; INTERFERON-ALPHA; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; PREDNISOLONE; PROTEIN-LOSING ENTEROPATHIES;

EID: 34250008974     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.06.003     Document Type: Article

References (12)

1. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine (2004), Mc Graw Hill, New York
2. Ammann R.W., Vetter D., Deyhle P., Tschen H., Sulser H., and Schmid M. Gastrointestinal involvement in systemic mastocytosis. Gut 17 (1976) 107-112
3. Borda F., Uribarrena R., and Rivero-Puente A. Gastroscopic findings in systemic mastocytosis. Endoscopy 15 (1983) 342-343
4. Scolapio J.S., Wolfe III J., Malavet P., and Woodward T.A. Endoscopic findings in systemic mastocytosis. Gastrointest Endosc 44 (1996) 608-610
5. Takasaki Y., Tsukasaki K., Jubashi T., Tomonaga M., Kamihira S., and Makiyama K. Systemic mastocytosis with extensive polypoid lesions in the intestines; successful treatment with interferon-alpha. Intern Med 37 (1998) 484-488
6. Lambert I., Fransis S., Ectors N., Desreumaux P., and Geboes K. Macrophage collections in gastrointestinal biopsies and metabolic disorders: two unusual case reports. Histopathology 42 (2003) 196-198
7. Jensen R.T. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am 14 (2000) 579-623
8. Siegert S.I., Diebold J., Ludolph-Hauser D., and Lohrs U. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?. Am J Clin Pathol 122 (2004) 560-565
9. Stankovic K., Sarrot-Reynauld F., Puget M., Massot C., Ninet J., Lorcerie B., et al. Systemic mastocytosis: predictable factors of poor prognosis present at the onset of the disease. Eur J Intern Med 16 (2005) 387-390
10. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). WHO-pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon
11. Valent P., Akin C., Sperr W.R., Escribano L., Arock M., Horny H.P., et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 27 (2003) 635-641
12. Butterfield J.H. Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis. Acta Haematol 114 (2005) 26-40